This bill mandates that public schools maintain a supply of epinephrine auto-injectors for use during allergic emergencies, ensuring that a school nurse is responsible for determining the quantity and type of medication needed. It also requires schools to submit an annual report to the Department of Education summarizing the supply and usage of these auto-injectors. Additionally, the bill stipulates that designated assistive personnel must be identified by the school nurse in consultation with the principal to ensure coverage throughout the school day. The definition of "epinephrine auto-injectors" is expanded to include FDA-approved epinephrine nasal spray.

Furthermore, the bill includes an appropriation of $1 for the fiscal year ending June 30, 2026, to reimburse school districts for maintaining these supplies. The governor is authorized to draw from the treasury for this purpose, and the appropriation is designed not to lapse. The bill will take effect on July 1, 2025. The fiscal impact on local school districts is indeterminable, as costs will vary by district, and the Department of Education's administrative costs for processing reimbursement requests are also unknown.

Statutes affected:
Introduced: 200:44-a, 200:42